222 related articles for article (PubMed ID: 11769075)
1. [Endovesical immunotherapy: Calmette-Guérin bacillus].
Chopin D; Saint F; Gattegno B
Prog Urol; 2001 Nov; 11(5):1067-115. PubMed ID: 11769075
[No Abstract] [Full Text] [Related]
2. [Calmette-Guerin bacillus disseminated infection after intravesical instillation].
Borré S; Brustia D; Rosa F; Brondolo R; Rizzo G; Garavelli PL
Recenti Prog Med; 2002 Apr; 93(4):247-8. PubMed ID: 11989131
[TBL] [Abstract][Full Text] [Related]
3. Intravesical Bacillus Calmette-Guerin for treating bladder cancer.
Boyd LA
Urol Nurs; 2003 Jun; 23(3):189-91, 199; quiz 192. PubMed ID: 12861735
[TBL] [Abstract][Full Text] [Related]
4. Results of inadvertent administration of bacillus Calmette-Guerin for treatment of transitional cell carcinoma of bladder.
Yarmohammadi A; Ahmadinia H; Abolbashari M; Molaei M
Urol J; 2007; 4(2):121-2. PubMed ID: 17701934
[No Abstract] [Full Text] [Related]
5. Re: Agarwal a et al.: The safety and efficacy of different doses of bacillus Calmette Guerin in superficial bladder transitional cell carcinoma (Urology 2007;70:1075-1078).
Agrawal MS; Bansal S
Urology; 2009 Feb; 73(2):450-1. PubMed ID: 19185768
[No Abstract] [Full Text] [Related]
6. Re: Agrawal et al.: The safety and efficacy of different doses of bacillus Calmette-Guérin in superficial bladder transitional cell carcinoma. (Urology 2007;70:1075-1078).
Simone G; Leonardo C; Gallucci M
Urology; 2008 Nov; 72(5):1187-8. PubMed ID: 18774592
[No Abstract] [Full Text] [Related]
7. Small bladder and multiple urethral recurrences after intravesical instillation of bacillus Calmette-Guerin for superficial transitional cell carcinoma of the bladder.
Manasia P; Alcaraz A; Cetina A; Alcover J
J Urol; 2001 Feb; 165(2):529-30. PubMed ID: 11176420
[No Abstract] [Full Text] [Related]
8. Treatment of carcinoma in situ with intravesical bacillus Calmette-Guerin without maintenance.
Griffiths TR; Charlton M; Neal DE; Powell PH
J Urol; 2002 Jun; 167(6):2408-12. PubMed ID: 11992047
[TBL] [Abstract][Full Text] [Related]
9. [Urinary leukocytes as a new prognostic marker of therapeutic response and of adverse effects associated with the maintenance treatment with endovesical BCG, for the prophylaxis of superficial bladder tumors].
Saint F; Irani J; Salomon L; Legrand P; Abbou CC; Chopin D
Prog Urol; 2001 Dec; 11(6):1242-50. PubMed ID: 11859659
[TBL] [Abstract][Full Text] [Related]
10. Tubercular prostatic abscess as a complication of intravesical bacillus Calmette-Guérin immunotherapy.
Aust TR; Massey JA
Int J Urol; 2005 Oct; 12(10):920-1. PubMed ID: 16323989
[TBL] [Abstract][Full Text] [Related]
11. [Prospective study of the results at 2 years of one or two cycles of BCG endovesical instillations in the urothelial tumors of the bladder pT1 G3 after completed transurethral resection].
Rischmann P; Gamé X; Mazerolles C; Bittard H; Bouchot O; Descottes JL; Chopin D
Prog Urol; 2005 Dec; 15(6 Suppl 1):1266-70. PubMed ID: 16734216
[No Abstract] [Full Text] [Related]
12. Vitiligo--an autoimmune side-effect of intravesical bacillus Calmette-Guérin instillation?
Beisland C; Holsen DS
Scand J Urol Nephrol; 2004; 38(2):182-3. PubMed ID: 15204415
[TBL] [Abstract][Full Text] [Related]
13. Long-term results of intravesical bacillus Calmette-Guérin therapy for stage T1 superficial bladder cancer.
Droller MJ
J Urol; 2001 Feb; 165(2):701-2. PubMed ID: 11233047
[No Abstract] [Full Text] [Related]
14. Prostatorectal fistula following intravesical bacillus Calmette-Guérin immunotherapy for carcinoma in situ of the urinary bladder.
Enatsu N; Ota T; Ochi A
Int J Urol; 2010 Sep; 17(9):822-3. PubMed ID: 20727055
[No Abstract] [Full Text] [Related]
15. Bladder and penile lesions with inguinal adenopathy after intravesical Bacillus Calmette-Guerin (BCG) treatment.
Yates J; Stein B
Urology; 2007 Dec; 70(6):1223.e15-7. PubMed ID: 18158061
[TBL] [Abstract][Full Text] [Related]
16. Transient anuria requiring nephrostomy after intravesical bacillus Calmette-Guérin instillations for superficial bladder cancer.
Kaneko T; Fujita K; Homma Y
Int J Urol; 2006 Mar; 13(3):294-5. PubMed ID: 16643629
[TBL] [Abstract][Full Text] [Related]
17. Thirty-five years of intravesical bacillus Calmette-Guérin for bladder cancer: where now?
Catto JW
Eur Urol; 2011 Jul; 60(1):37-8. PubMed ID: 21543152
[No Abstract] [Full Text] [Related]
18. Editorial comment to Maintenance intravesical bacillus Calmette-Guérin instillation for Ta, T1 cancer and carcinoma in situ of the bladder: randomized controlled trial by the BCG Tokyo Strain Study Group.
Mostafid H
Int J Urol; 2010 Sep; 17(9):766-7. PubMed ID: 20727047
[No Abstract] [Full Text] [Related]
19. [Relapsing Reiter's syndrome after Bacillus Calmette-Guérin immunotherapy for bladder carcinoma].
Pego JM; Lamas C; Hernández I; Suso J
Med Clin (Barc); 2003 Sep; 121(9):356-7. PubMed ID: 14499076
[No Abstract] [Full Text] [Related]
20. An unexpected complication of bacillus Calmette-Guérin therapy.
Yildiz H; Colin G; Lambert M
Acta Clin Belg; 2014 Aug; 69(4):312. PubMed ID: 24846180
[No Abstract] [Full Text] [Related]
[Next] [New Search]